ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer

NCT00387608 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

NIH

Sponsor class

Conditions

Leukemia
Lymphoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: veliparib
OTHER: pharmacological study
PROCEDURE: biopsy

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]